= singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Mass spectra were obtained on a matrix-assisted laser desorption/ionization time of flight mass spectrometry MS (MALDI-TOF, Bruker AutoFlex III system). The ultraviolet-visible (UV-vis) absorption, fluorescence and chemiluminiscence spectra were measured by a Shimadzu UV-vis spectrophotometer (UV-3600) and fluorescence spectrophotometer with a photomultiplier tube detector, respectively. The molecular weights (Mn) and polydispersities (PDI) of the polymers were determined by gel permeation chromatography (GPC) analysis on a Shim-pack GPC-80X column with water as the S3 eluent at a flow rate of 1.0 mL min -1 . Dynamic light scattering (DLS) was performed on a particle size analyzer (NanoBrook 90Plus, Brookhaven Instruments Corporation).
Transmission electron microscopy (TEM) images were performed on a HT7700 transmission electron microscope operating at 100 kV. The methyl thiazolyl tetrazolium (MTT) assay was performed by a PowerWave XS/XS2 microplate spectrophotometer (BioTek, Winooski, VT). Images were acquired by IVIS living imaging system.
Statistical analysis
Statistical analyses of the data were performed with the SPSS 12.0 software.
Measurement data are expressed as the mean ± SD. For cell viability assays, a Student's t-test was applied to identify significant differences. Multiple group comparison was conducted by one-way analysis of variance (ANOVA). A value of p < 0.05 was considered statistically significant.
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Methods
Synthetic route to the compound PEAZO and PCD. 1 
Synthesis of 2.
Monomer 2 was synthesized according to previous report. 4 Monomer 1 (1.746 g, 6 mmol), potassium carbonate (0.8295 g, 6 mmol) and iodoethane (0.936 g, 6 mmol) was dissolved in DMF (15 mL). The solution was stirred for 24 h at 60 0 C and cooled to room temperature. Then the reaction mixture was poured into 500 mL water and filtered to get the precipitate, which was then purified via silica gel column chromatography (hexane/ethyl acetate = 3/1) (Yield: 79% 
Synthesis of 3.
Monomer 3 was synthesized according to previous report. 4 
Synthesis of 4.
Monomer 4 was synthesized according to previous report. 4 Monomer 3 (2.0 g, 6 mmol) and potassium carbonate (0.033 g, 0.239 mmol) were dissolved in a mixture of THF (6 mL) and methanol (65 mL). The solution was stirred for 4 h at room temperature. The mixture was extracted with ethyl acetate. After the organic layer was dried with anhydrous magnesium sulfate, the solvent was removed by evaporation. The product was purified by silica gel column chromatogrqaphy (ethyl acetate/chloroform = 1:1) (yield = 90% 
Synthesis of 5.
A mixture of 4-iodophenol (2.2 g, 10 mmol), 6-chlorohexan-1-ol (1.36 g, 10 mmol) and potassium carbonate (1.5 g, 11 mmol) was dissolved in DMF (30 mL). The reaction mixture was refluxed with stirring for 3 h and cooled to room temperature. Water was added to the mixture and the precipitate was collected. The crude product was purified via silica gel column chromatography (hexane-ethyl acetate = 2/1) (Yield: 76% 
Synthesis of 6.
Monomer 6 was synthesized according to previous report. 4 Compound 5 (2.9 g, 9.1 mmol), compound 4 (2.0 g, 7.6 mmol), PdCl 2 (PPh 3 ) 2 (0.27 g, 0.38 mmol), CuI (0.27 g, 0.98 mmol), and PPh 3 (0.37 g, 1.9 mmol) were dissolved in trimethylamine (30 mL) and THF (30 mL). The mixture was stirred at 60 °C for 8 h under a nitrogen atmosphere.
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The resulting solution was cooled to room temperature and extracted with ethyl acetate.
After the organic layer was dried with anhydrous magnesium sulfate, the solvent was removed by evaporation. The product was purified by column chromatogrqaphy (silica gel, ethyl acetate: hexane = 1:1 as eluent) to yield 2.0 g (58%) of orange powder. 1 
Synthesis of 7 (EAZO).
Monomer 7 was synthesized according to previous report. 6 (9.0 g, 20 mmol), tosyl chloride (11.40 g, 60 mmol) and pyridine (20 mL) were dissolved in dichloromethane (250 mL). The resulting solution was stirred at 20 °C for 16 h. The reaction mixture was diluted with water (200 mL). The organic layer was washed with equivalent volumes of water several times. The organic layer was washed with brine twice and dried over magnesium sulfate, the solvent was evaporated under reduced pressure, and the crude product was used the next step. The crude product was used the next step.
The crude product (5.85 g, 10 mmol) and potassium phthalimide (2.09 g, 11.28 mmol)
were dissolved in dimethylformamide (250 mL) and stirred at 80 °C for 16 h.
Afterward, the reaction mixture was allowed to cool to room temperature and was diluted with ethyl acetate (250 mL). The organic layer was washed with equivalent volumes of water several times; the combined aqueous phases were extracted twice with ethyl acetate (150 mL) each. The organic layer was washed with brine twice and dried over magnesium sulfate, the solvent was evaporated under reduced pressure, and S9 the crude product dissolved in ethanol (20 mL) was cooled to 0 °C, and hydrazine hydrate (1 mL) was added slowly. After stirring for 15 min at 0 °C the reaction was refluxed for 3 h. The reaction was allowed to cool to room temperature, diluted with 4 M HCl (200 mL), and filtered, and the filtrate was washed with dichloromethane (100 mL) before being basified to pH 14 with concentrated NaOH solution. The water phase was extracted five times with dichloromethane (100 mL), the extracts were combined and dried over Na 2 SO 4 , and the solvent was evaporated to give the desired compound in 61% yield. 1 
Synthesis of PEAZO.
Polymer PEAZO was synthesized according to previous report. 2 Poly(methyl vinyl ether-alt-maleic anhydride) (800 mg, Mn = 80 kDa), 7 (100 mg) and DIPEA (1 mL)
were dissolved in 200 mL of dry THF. The mixture was stirred for 16 h at 50 °C. After THF evaporation, the material was resuspended in water with small excess of NaOH with respect to the carboxylic groups on the polymer backbone. After evaporation of water and DIPEA, the remaining residue was dissolved in water. Then the solution was dialyzed (dialysis membrane MWCO 3500) against DI water for 3 day. After dialysis, the result solution was filtered through a 0.45 μm filter and then lyophilized at room temperature for 3 days to obtain a yellow powder. The conjugation ratios of PEAZO S10 within each the backbone polymer chain were about 36 EAZO molecules. (GPC: Mn = 95 kDa, PDI = 1.56).
Synthesis of PCD.
Polymer PCD was synthesized according to previous report. 2 
The emission-reabsorption studies
The emission-reabsorption process using an experimental setup as previously reported. 4 CPT, CPPO, PCD and H2O2 (2 mM) in beaker to produce blue CL, and the generated CL emission to irradiate a PBS solution of the PEAZO-PCD NPs in a highly optically transparent cell. The no CL of CPT as control through equal PBS instead of H 2 O 2 in a beaker, everything else is absolutely identical. Highly optically transparent cell was continuously irradiated three times by blue CL. Each time the beaker is filled with fresh CPT, CPPO, PCD and H 2 O 2 (2 mM).
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Preparation of PEAZO-PCD NPs.
PEAZO (36 mg) and PCD (12 mg) (molar ratio of EAZO/β-CD-NH 2 = 1:2) was dissolved in mlli-Q water (8 mL), and stirred for 24 h at room temperature in darkness.
The supernatant (PEAZO-PCD NPs) was filtered through a 0.22 μm filter. Then, the homogeneous PEAZO-PCD NPs solution was lyophilized.
Drug loading on nanoparticles. PCD (36 mg) was dissolved in mlli-Q water (8 mL), and then added PEAZO (12 mg). The resulting solution was slowly added into 2 mL DMSO solution containing CPT (5 mg mL -1 ) and CPPO (5 mg mL -1 ), and stirred for 24 h at room temperature in darkness. The supernatant was filtered through a 0.22 μm filter to remove the excess CPT and CPPO. Then, the resulting filtrate was diluted and stored in fridge at 4 o C for further use.
CPT releasing in vitro.
Methods were demonstrated as previous reports. 5, 6 The release profiles were studied by monitoring the increase of CPT concentration in culture 4T1 Tumor Animal models.
In vivo blood elimination kinetics. Methods were demonstrated as previous reports.
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The jugular vein of Female BALB/c nude mice bearing 4T1 tumors (~90 mm 3 ) was cannulated and a catheter was implanted for intravenous injection and blood collection (Harland, Indianapolis, IN, USA). IR825-loaded CLDRSs were injected through the catheter at a dose of 5 mg kg -1 body weight (n = 3 for each group). Whole blood samples (~100 μL) were collected via jugular vein catheter before dosing and at predetermined time points post injection and used to detect IR825 concentration by the measurement of absorbance at 800 nm on a Shimadzu UV-vis spectrophotometer (UV-3600). The values were plotted versus time after the subtraction of blood background. 
